Abstract:Objective:To observe the effects of transurethral split of the prostate (TUSP) on the urodynamics, the sexual function and the quality of life of benign prostatic hyperplasia.Methods:Eighty patients with benign prostatic hyperplasia admitted to the Deqing People′s Hospital of Zhejiang Province from January 2017 to June 2019 were enrolled into the research objects prospectively. According to the random digits table method, they were divided into group A and group B, with 40 cases in each group. The group A was treated with TUSP, while the group B was treated with bipolar transurethral plasma kinetic prostatectomy (TUPKP). The operation time, intraoperative blood loss, bladder irrigation time, urinary catheter indwelling time, hospitalization time of the two groups were compared and surgical effects were evaluated. The changes of hemoglobin (Hb), serum sodium (Na), post-void residual volume (PVR), maximum urinary flow rate (Q max), international prostate symptom score (IPSS) and international index of erectile function score (IIEF-5), the quality of life index (QOL) of 2 groups before and after the operation were measured. Surgical complications were recorded. Results:The operation time, bladder irrigation time, urinary catheter indwelling time and hospital stay in group A were all shorter than that in group B: (15.63 ± 4.17) min vs. (58.79 ± 10.45) min, (6.26 ± 1.17) h vs. (45.51 ± 10.03) h, (3.07 ± 0.68) d vs. (5.67 ± 1.51) d, (3.63 ± 0.43) d vs. (6.08 ± 1.72) d, (18.32 ± 2.79) ml vs. (65.26 ± 20.64) ml, and there were statistical differences ( P<0.05); there were no statistical difference between 2 groups in surgical curative effect grade and Na 1 d after operation ( P>0.05); 1 day after operation, Hb in group A was higher than that in group B: (115.63 ± 9.78) g/L vs. (109.65 ± 8.36) g/L, and there was statistical difference ( P<0.05); PVR, Q max, IPSS, IIEF-5 and QOL 3 and 6 months after surgery were improved in 2 groups ( P<0.05), but the difference between 2 groups was not statistically significant ( P>0.05); the total complication rate in group A was lower than that in group B: 10.00% (4/40) vs. 27.50% (11/40), and there was statistical difference ( P<0.05). Conclusions:TUSP and TUPKP are equally effective in the treatment of benign prostatic hyperplasia, both of which can improve the symptoms of prostatic hyperplasia, improve the quality of life and improve sexual function. But TUSP has less intraoperative bleeding, shorter operation time, faster postoperative recovery, fewer complications, and higher safety.

Clinical Analysis on the High-Risk BPH Treated by Partial Transurethral Remove of Prostate and Oral Finasteride (69 Cases)

The value of transurethral cylindrical dilatation of the prostate in the treatment of patients with benign prostatic hyperplasia

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

Evaluation on Safety and Efficacy of Finasteride in Treatment of Benign Prostatic Hyperplasia

The Clinical Safety and Efficacy of PKRP and TURP in the Treatment of Patients with Benign Prostatic Hyperplasia Prostate(volume>60 Ml):A Compared Study

Transurethral columnar balloon dilation of prostate for benign prostatic hyperplasia in middle-aged and high-risk patients

The research of Finasteride and Tamsulosin to reduce hemorrhage during TURP

Quantitative Study On The Effect Of Finasteride On Intraoperative Bleeding And Irrigating Fluid Absorption During Transurethral Resection Of Prostate

The curative effect analysis of transurethral plasmakinetic enucleation and resection of the prostate for patients with small and medium-sized benign prostatic hyperplasia

Clinical effects of long-term use of finasteride in treatment of patients with benign prostatic hyperplasia

Clinical Efficacy of TKRP Surgery and Its Effect on Serum PSA Level for Treating the Patients with Benign Prostatic Hyperplasia

[Cost and Effectiveness Analysis of Treatments for Benign Prostatic Hyperplasia].

Comparison of Transurethral Photoselective Vaporization and Transurethral Resection of the Prostate for the Treatment of Benign Prostatic Hyperplasia

Clinical observation of Qianlie Shutong Capsules combined with finasteride in treatment of benign prostatic hyperplasia

Transurethral Resection of Prostate for Treatment of High-risk Patients with Large Volume Benign Prostatic Hyperplasia

Study on the efficacy and safety of Transurethral enucleation and resection of the prostate in treatment of IV grade Benign prostatic hyperplasia

Analysis of senior and high risk benign prostatic hyperplasia by treated transurethral vaporization resection of the prostate

Effect of transurethral bipolar plasmakinetic resection of prostate on patients with benign prostatic hyperplasia

Observation on Curative Efficacy of Tamsulosin Hydrochloride Sustained-Release Capsules Combined with Finasteride Tablets in the Treatment of Benign Prostatic Hyperplasia

Transurethral Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia